COVID 19
Conditions
Interventions
Intervention group:Paxlovid combined with routine treatment
Control group:Routine treatment
Sponsors
The Ninth People Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
61 Years to 95 Years
Inclusion criteria
Inclusion criteria: 1.Patients with confirmed COVID-19 and not receiving systematic treatment 2.Patients with paxlovid treatment indications in accordance with the diagnosis and treatment scheme for novel coronavirus (trial version 9) 3.Age >= 60 4.All patients who did not have drug contraindications and agreed to paxlovid treatment were included in the trial group 5.All patients who used drugs prohibited to be combined with paxlovid, such as amiodarone, carbamazepine, diazepam and phenobarbital, were included in the control group 6.Voluntary or authorized agent to sign informed consent
Exclusion criteria
Exclusion criteria: 1.Recently, the patients with new coronal infection became negative and then became positive again; 2.Patients with second or more infections.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nucleic acid shedding time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Severe rate;Symptom disappearance time;Adverse events; | — |
Countries
China
Contacts
Public ContactLi Yi
The Ninth People Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Outcome results
None listed